HSRx 351

Drug Profile

HSRx 351

Alternative Names: Oseltamivir/berry-extract

Latest Information Update: 05 Dec 2016

Price : $50

At a glance

  • Originator HerbalScience Group
  • Developer HSRx Biopharmaceutical
  • Class Antivirals; Herbal medicines; Small molecules
  • Mechanism of Action Neuraminidase inhibitors; Virus attachment inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Influenza virus infections

Most Recent Events

  • 05 Aug 2015 HSRx Biopharmaceutical in-licenses 8 proprietary pharmaceutical products from HerbalScience Group
  • 01 Nov 2014 Phase-II clinical trials in Influenza virus infections (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top